Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Benzalkonium chloride is a mixture of alkylbenzyldimethylammonium chlorides (quaternary ammonium salts) containing various even-numbered alkyl chain lengths, most commonly C12–C16, formulated as a colorless to yellow, viscous liquid or powder. It acts as a broad-spectrum antimicrobial agent by disrupting the lipid membranes of bacteria, fungi, and enveloped viruses, leading to cell death. Benzalkonium chloride is used as an active antiseptic and disinfectant agent in topical pharmaceuticals, multidose ophthalmic and nasal formulations, cleaning agents, hand sanitizers, and surface disinfectants. Its cationic surfactant properties also make it useful as a preservative and solubilizer, but its use can cause irritation and, rarely, sensitization. It is not a biological drug target (e.g., receptor, enzyme), but rather an antimicrobial chemical frequently used in healthcare and consumer products.
Disrupts microorganism cell membrane integrity by integrating into and solubilizing lipid bilayers, leading to leakage of cellular contents and cell death - Acts as a cationic surfactant, interfering with microbial enzymes and metabolic pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Benzalkonium chloride (BKC (also commonly BZK, BAK, BAC)).